1. Home
  2. FOLD vs VAC Comparison

FOLD vs VAC Comparison

Compare FOLD & VAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • VAC
  • Stock Information
  • Founded
  • FOLD 2002
  • VAC 1984
  • Country
  • FOLD United States
  • VAC United States
  • Employees
  • FOLD N/A
  • VAC N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • VAC Real Estate
  • Sector
  • FOLD Health Care
  • VAC Finance
  • Exchange
  • FOLD Nasdaq
  • VAC Nasdaq
  • Market Cap
  • FOLD 2.9B
  • VAC 2.3B
  • IPO Year
  • FOLD 2007
  • VAC N/A
  • Fundamental
  • Price
  • FOLD $6.83
  • VAC $53.18
  • Analyst Decision
  • FOLD Strong Buy
  • VAC Buy
  • Analyst Count
  • FOLD 9
  • VAC 8
  • Target Price
  • FOLD $17.00
  • VAC $97.13
  • AVG Volume (30 Days)
  • FOLD 3.9M
  • VAC 586.5K
  • Earning Date
  • FOLD 05-08-2025
  • VAC 05-07-2025
  • Dividend Yield
  • FOLD N/A
  • VAC 5.94%
  • EPS Growth
  • FOLD N/A
  • VAC N/A
  • EPS
  • FOLD N/A
  • VAC 5.63
  • Revenue
  • FOLD $528,294,999.00
  • VAC $3,278,000,000.00
  • Revenue This Year
  • FOLD $21.83
  • VAC $59.06
  • Revenue Next Year
  • FOLD $22.16
  • VAC $3.53
  • P/E Ratio
  • FOLD N/A
  • VAC $9.45
  • Revenue Growth
  • FOLD 32.29
  • VAC 3.54
  • 52 Week Low
  • FOLD $6.20
  • VAC $49.22
  • 52 Week High
  • FOLD $12.65
  • VAC $103.51
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 32.01
  • VAC 35.65
  • Support Level
  • FOLD $6.20
  • VAC $51.63
  • Resistance Level
  • FOLD $6.95
  • VAC $54.81
  • Average True Range (ATR)
  • FOLD 0.43
  • VAC 4.20
  • MACD
  • FOLD -0.04
  • VAC 0.03
  • Stochastic Oscillator
  • FOLD 29.86
  • VAC 23.84

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About VAC Marriott Vacations Worldwide Corporation

Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.

Share on Social Networks: